Home » Topics » BioWorld Science

BioWorld Science
RSS

FDA approves Lynparza as first-line maintenance treatment for gBRCAm metastatic pancreatic cancer

Dec. 30, 2019

Phase III MOMENTUM trial of AXS-08 for migraine meets coprimary endpoints

Dec. 30, 2019

AstraZeneca begins first-in-human study of AZD-0466

Dec. 30, 2019

Tislelizumab approved in China for classical Hodgkin's lymphoma

Dec. 30, 2019

Remimazolam tosylate obtains first approval in China

Dec. 30, 2019

China NMPA approves Sinovac's varicella vaccine

Dec. 30, 2019

By spying on quorum sensing, immune system picks its battles

Dec. 30, 2019

Oral compound ameliorates beta-thalassemia

Dec. 30, 2019

GABRA5 positive allosteric modulators designed at Roche

Dec. 30, 2019

Muscarinic M1 receptor PAMs reported in Vanderbilt University patent

Dec. 30, 2019

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...